Birdwatch Archive

Birdwatch Note

2024-04-17 02:48:43 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

実際には副反応検討部会は心筋炎を重大な副反応として加える事に了承する等、対応をとる時はとっています↓ https://www.m3.com/news/open/iryoishin/989643 例えばこの時の判断としては海外で心筋炎の客観的な医療記録の接種後の増大が何度も確認された事や国内の網羅性のない疑い報告でも常時の心筋炎の医療記録頻度より上回っていました https://www.m3.com/news/open/iryoishin/989643 国外(メタ解析 https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00059-5/fulltext?amp=1 国内 https://www.niid.go.jp/niid/ja/2019-ncov/2484-idsc/10984-covid19-75.html 腎疾患に関しては一方で100万~数百万の母集団やそこから生じた腎不全や腎障害・腎炎の医療記録を調べいずれも対照条件と比べた接種直後の新規医療記録の上昇が検出ができず↓ https://www.nejm.org/doi/full/10.1056/nejmoa2110475 https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004018 https://link.springer.com/article/10.1007/s40264-023-01332-1 https://www.sciencedirect.com/science/article/pii/S0085253822006974 腎臓学会もIgA腎症は大半は重篤でなく一過性としています↓ https://jsn.or.jp/medic/covid19/notice/content-30.php https://twitter.com/jsnorjp/status/1506514395312328705

Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1780355490595377354

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1780428147022065991
  • noteId - 1780428147022065991
  • participantId -
  • noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
  • createdAtMillis - 1713322123662
  • tweetId - 1780355490595377354
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 1
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • 実際には副反応検討部会は心筋炎を重大な副反応として加える事に了承する等、対応をとる時はとっています↓ https://www.m3.com/news/open/iryoishin/989643 例えばこの時の判断としては海外で心筋炎の客観的な医療記録の接種後の増大が何度も確認された事や国内の網羅性のない疑い報告でも常時の心筋炎の医療記録頻度より上回っていました https://www.m3.com/news/open/iryoishin/989643 国外(メタ解析 https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00059-5/fulltext?amp=1 国内 https://www.niid.go.jp/niid/ja/2019-ncov/2484-idsc/10984-covid19-75.html 腎疾患に関しては一方で100万~数百万の母集団やそこから生じた腎不全や腎障害・腎炎の医療記録を調べいずれも対照条件と比べた接種直後の新規医療記録の上昇が検出ができず↓ https://www.nejm.org/doi/full/10.1056/nejmoa2110475 https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004018 https://link.springer.com/article/10.1007/s40264-023-01332-1 https://www.sciencedirect.com/science/article/pii/S0085253822006974 腎臓学会もIgA腎症は大半は重篤でなく一過性としています↓ https://jsn.or.jp/medic/covid19/notice/content-30.php https://twitter.com/jsnorjp/status/1506514395312328705

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-04-17 02:48:43 UTC
(1713322123662)
2024-04-17 11:36:34 UTC
(1713353794960)
CURRENTLY_RATED_HELPFUL 2024-04-18 01:52:12 UTC
(1713405132780)
CURRENTLY_RATED_HELPFUL 2024-04-17 11:36:34 UTC
(1713353794960)
CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2024-04-17 09:53:20 -0500 Rating Details
2024-04-17 09:37:02 -0500 Rating Details
2024-04-17 05:12:30 -0500 Rating Details
2024-04-17 04:45:41 -0500 Rating Details
2024-04-17 04:35:38 -0500 Rating Details
2024-04-17 04:26:09 -0500 Rating Details
2024-04-17 04:18:38 -0500 Rating Details
2024-04-17 03:12:43 -0500 Rating Details
2024-04-17 02:53:33 -0500 Rating Details
2024-04-17 00:05:09 -0500 Rating Details
2024-04-16 23:13:48 -0500 Rating Details
2024-04-16 23:09:24 -0500 Rating Details
2024-04-16 23:07:20 -0500 Rating Details
2024-04-16 22:58:27 -0500 Rating Details
2024-04-16 22:49:30 -0500 Rating Details
2024-04-16 22:43:09 -0500 Rating Details
2024-04-16 22:41:34 -0500 Rating Details
2024-04-16 22:40:54 -0500 Rating Details
2024-04-16 22:33:40 -0500 Rating Details
2024-04-16 22:26:23 -0500 Rating Details
2024-04-16 22:07:31 -0500 Rating Details
2024-04-18 00:52:03 -0500 Rating Details
2024-04-17 10:57:18 -0500 Rating Details
2024-04-17 09:06:22 -0500 Rating Details
2024-04-17 06:11:32 -0500 Rating Details
2024-04-17 03:53:00 -0500 Rating Details
2024-04-17 03:13:51 -0500 Rating Details
2024-04-17 01:54:57 -0500 Rating Details
2024-04-16 23:41:32 -0500 Rating Details
2024-04-16 23:05:12 -0500 Rating Details
2024-04-16 22:51:11 -0500 Rating Details
2024-04-16 22:45:53 -0500 Rating Details
2024-04-16 22:45:29 -0500 Rating Details
2024-04-16 22:45:02 -0500 Rating Details
2024-04-16 22:41:07 -0500 Rating Details
2024-04-16 22:29:49 -0500 Rating Details
2024-04-16 22:22:03 -0500 Rating Details
2024-04-16 22:09:45 -0500 Rating Details
2024-04-16 22:04:49 -0500 Rating Details
2024-04-20 16:20:41 -0500 Rating Details
2024-04-22 10:16:40 -0500 Rating Details
2024-04-29 04:29:18 -0500 Rating Details
2024-04-20 19:39:08 -0500 Rating Details
2024-04-17 04:03:31 -0500 Rating Details
2024-04-17 03:31:01 -0500 Rating Details
2024-04-17 03:12:02 -0500 Rating Details
2024-04-17 02:52:50 -0500 Rating Details
2024-04-17 02:36:37 -0500 Rating Details
2024-04-17 02:28:21 -0500 Rating Details
2024-04-17 02:24:54 -0500 Rating Details
2024-04-17 02:13:55 -0500 Rating Details
2024-04-17 01:59:44 -0500 Rating Details
2024-04-17 01:59:04 -0500 Rating Details
2024-04-17 01:01:30 -0500 Rating Details
2024-04-16 23:16:09 -0500 Rating Details
2024-04-16 23:03:11 -0500 Rating Details
2024-04-16 22:58:03 -0500 Rating Details
2024-04-16 22:41:53 -0500 Rating Details
2024-04-16 22:39:44 -0500 Rating Details
2024-04-16 22:38:16 -0500 Rating Details
2024-04-16 22:35:45 -0500 Rating Details
2024-04-16 22:27:23 -0500 Rating Details
2024-04-16 22:13:31 -0500 Rating Details
2024-04-16 22:04:07 -0500 Rating Details
2024-04-16 22:04:06 -0500 Rating Details
2024-04-20 21:34:06 -0500 Rating Details
2024-04-20 16:30:26 -0500 Rating Details